Please assess the completion status of the following clinical trial:

Trial Title: Supplemental Parenteral Nutrition in Pediatric Respiratory Failure

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Admitted to study hospital pediatric intensive care unit (PICU),~2. One month to 16 years of age,~3. Exhibits Acute Hypoxemic Respiratory Failure as defined as: PaO2/FiO2 ≤ 300 or SpO2/FiO2 ≤ 260, No evidence of cardiac dysfunction, Mechanically ventilated,~4. Require artificial nutrition,~5. Anticipate placement of central venous line within 24 hours of admission~Exclusion Criteria:~1. Premature infants and neonates \< 37 weeks corrected gestational age,~2. Transfer patient on an established enteral or parenteral nutritional regimen,~3. Known allergy to lactulose or mannitol,~4. Pregnant,~5. Admit BMI \>30,~6. Thoracic trauma, abdominal trauma, and/or active intracranial bleeding,~7. Anuric renal failure, previous bowel surgery and/or short gut syndrome,~8. Cannot be enterally fed within 24 hours of admission according to the admitting physician,~9. On extracorporeal membrane oxygenation (ECMO),~10. Expected survival \<24 hours or limitations to aggressive ICU care (DNR),~11. Receiving active CPR when admitted to the PICU,~12. A pre-existing bronchopleural fistula,~13. Previously enrolled and randomized into this protocol,~14. Actively enrolled in another clinical trial which at the discretion of the PI would conflict with this study.

- Gender: ALL
- Minimum Age: 1 Month
- Maximum Age: 16 Years
- Healthy Volunteers: f

Study Arms:
- Early Parenteral Nutrition (Type: EXPERIMENTAL): Patients receive supplemental parenteral nutrition within 12 hours of enrollment. Titrated with enteral nutrition to achieve target goal calories and protein.
- Late Parenteral Nutrition (Type: ACTIVE_COMPARATOR): Patients receive supplemental parenteral nutrition 96 hours after enrollment. Titrated with enteral nutrition to achieve target goal calories and protein.

Based on this trial design, predict the completion outcome and termination type (if applicable).